SLDB — Key levels to watch:

Today's positive trial data pushed Solid Bioscience's stock above $7 before the offering news weighed on upside momentum. Despite this, I have my eye on a key multi-month trendline that suggests potential support around $4.48, which remains 11.17% above the offering price of $4.03.

This level aligns with prior trendline resistance on the downtrend, now potentially flipping to support. With strong initial trial results still in play, I’ll pull the trigger around $4.48 if it holds.

After more than three decades of trading, much of it focused on the biotech sector, I’ve learned that chasing these scenarios rarely ends well—patience always pays. IMHO, for those without a position, sitting on your hands and waiting for confirmation at support is likely the smarter move.

Chart tells the story—watch this level closely. Good luck to everyone. 📉📈